EYEspAI has filed 12 USPTO provisional patent applications in under 90 days — covering cryptographic AI authorization infrastructure, clinical trial integrity, institutional crypto custody, and digital identity sovereignty. Every core capability is protected.
The core patents protect the protocol itself — not a feature or an interface. Any competitor building cryptographic AI authorization infrastructure will be building on top of claimed art. The moat is at the foundation, not the surface.
The 12 applications don't describe 12 independent inventions. They describe one interconnected architecture — the authorization protocol, the key separation layer, the state machines, the vertical applications — with overlapping claim coverage across the stack.
12 applications in 90 days — from December 10, 2025 to February 20, 2026. Priority dates are established. Any technology developed independently but later to filing will not defeat these priority claims. The window to get ahead of this is closed.
First filing establishes the behavioral data collection architecture that seeds the entire IP portfolio.
Competitive intelligence profiles, PersonalSoul, PersonalDB, PersonalBank, and the foundational AMLSB security barrier all filed in rapid succession as the architecture crystallizes.
Thixotropic nanoparticle gel energy storage system — materials science patent for mobile and robotic platform infrastructure.
KSRS filing establishes the storage isolation architecture that makes VX records independently verifiable without platform trust.
Recipient Authority Confirmation filing — the mechanism that ties human identity to AI authorization, purpose-built for regulatory defensibility across financial services, healthcare, and legal.
The general cryptographic authorization protocol, the clinical trial application, and the institutional crypto custody application all filed on the same day — completing the vertical coverage of the Veridex stack.
Enterprise deployments, strategic licensing inquiries, and investor due diligence packages available on request. Reference clients provided under NDA.